The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium.
Enya DaynesMolly BaldwinNeil J GreeningThomas YatesNicolette C BishopGeorge MillsMatthew RobertsMalik HamrouniTatiana PlekhanovaIoannis VogiatzisCarlos EchevarriaRashmita NathuHamish J C McAuleyLorna LatimerJennifer GlennieFrancesca ChambersRuth PenfoldEmily HumeDimitrios MegaritisCharikleia AlexiouSebastian PotthoffMitchell James HoggCatherine HaightonBethany NicholOlivia C LeavyMatthew RichardsonOmer ElneimaAmisha SingapuriMarco SerenoRuth M SaundersVictoria C HarrisClaire M NolanCharlotte BoltonLinzy Houchen-WolloffEwen M HarrisonNazir LoneJennifer QuintJames D ChalmersLing-Pei HoAlex HorsleyMichael MarksKrisnah PoinasamyBetty RamenLouise V WainChristopher BrightlingWilliam D-C ManRachael EvansSally J SinghPublished in: Trials (2023)
Ethical approval was gained as part of the PHOSP-COVID study by Yorkshire and the Humber Leeds West Research NHS Ethics Committee, and the study was prospectively registered on the ISRCTN trial registry (ISRCTN13293865). Results will be disseminated to stakeholders, including patients and members of the public, and published in appropriate journals. Strengths and limitations of this study • This protocol utilises two interventions to support those with ongoing symptoms of COVID-19 • This is a two-centre parallel-group randomised controlled trial • The protocol has been supported by patient and public involvement groups who identified treatments of symptoms and activity limitation as a top priority.
Keyphrases
- coronavirus disease
- sars cov
- study protocol
- randomized controlled trial
- healthcare
- clinical trial
- public health
- machine learning
- emergency department
- systematic review
- end stage renal disease
- patient safety
- sleep quality
- respiratory syndrome coronavirus
- phase ii
- artificial intelligence
- quality improvement
- global health